Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
This study highlights the value of experimental vaccine trials as a rich source of therapeutic human monoclonal antibodies.Graphical Abstract
Source: Cell Reports - Category: Cytology Source Type: research
More News: Adenoviruses | Cytology | Ebola | Ebola Vaccine | Genetics | Guinea Health | Influenza | Influenza Vaccine | Men | Nanotechnology | Study | Vaccines